Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AnnuityVerse Releases Free Annuity Consumer Guide to Help Retirement Savers Navigate Income Planning with Greater Confidence
-
AI First Mate Built From 18,000 Miles at Sea
-
Standing Ovation raises $34.2 million to scale up its breakthrough technology for producing dairy proteins through precision fermentation, offering a sovereign and sustainable response to the surge in
-
Genflow Biosciences PLC Announces Total Voting Rights
-
Empire Metals Limited Announces Eclipse Mining Licence Sale Extension
-
Japan Post Insurance Invests in KKR’s Hoken Minaoshi Hompo Group
-
Wood Mackenzie partners with Special Olympics Asia Pacific to tackle gender gap in sport
-
NetDragon Upgraded to "A" by MSCI ESG Rating
-
Top Fire Restoration Vancouver Providers Compared
-
Avacta announces first patient treated in Phase 1 FOCUS-01 trial of FAP-Exd (AVA6103) - a sustained-release pre|CISION® exatecan peptide drug conjugate
-
Uxin Announces Official Opening of Its Tianjin Used Car Superstore
-
Materialise to Transfer RapidFit Business to Its Management Team
-
Quadient Collaborates with Lush Cosmetics to Transform Accounts Payable Operations with its AP Automation Software
-
Syensqo releases its 2025 Annual Integrated Report
-
STARTRADER Launches Web STAR Copy to Expand Social Trading Capabilities
-
onsemi Powers Sineng Electric’s Advanced Solar and Energy Storage Solutions
-
AI & Software Solutions Redefining Digital Transformation
-
Abbisko Therapeutics' FGFR2/3 Inhibitor ABSK061 Receives FDA IND Clearance for Achondroplasia in Children
-
Life Revisited: A Multidisciplinary Approach to the Purpose of Existence
-
Greater Globe Accelerates as Iran Conflict Reshapes Energy Choices
-
Casino Group: Status update on the project to adapt and strengthen the Casino Group’s financial structure
-
Miscellaneous
-
Regnology Announces Next-Generation Ascend Platform with Agentic AI, Advancing the Future of Regulatory Reporting
-
Alfasigma Reports Solid Performance in 2025 Supported by Double-Digit Revenue Growth in key strategic brands in Immunology (+17%¹), Gastroenterology (+15%), Vascular (+10%), and Consumer Healthcare e
-
Signadori Bio appoints Dr. Selwyn Ho, MB BS as Chief Executive Officer to lead company into next stage of growth
-
AviadoBio Advances AVB-101 Gene Therapy Program and Initiates Fourth Dose-Escalation Cohort of Phase 1/2 ASPIRE-FTD Trial
-
TotalEnergies SE: Disclosure of Transactions in Own Shares
-
FuneralExperts.com Joins Forces with NotifyNOW and InheritNOW to Transform Support for Bereaved Families Across the UK
-
Syngenta Group Reports 2025 Full Year Results
-
OpenBox AI Launches First Enterprise AI Trust Platform Built for Everyone, Backed by $5M Seed Round
-
Sentinel Capital Partners to Sell Spectrum Safety Solutions' Marioff Division
-
ROHM Adds New Lineup of 17 High-performance Op Amps Enhancing Design Flexibility
-
Diversified Energy TR-1
-
Diversification and innovation – the basis for stability
-
ALSTOM S.A: Alstom signs a new systems contract in the AMECA region
-
NBPE Announces Transaction in Own Shares
-
Equinor ASA: Share buy-back – first tranche for 2026
-
Notice to convene the Annual General Meeting of Shareholders of Aktsiaselts Tallinna Vesi
-
Sanoma’s Annual Report 2025 published
-
Holding(s) in Company
-
Progress on share buyback programme
-
Touchstone Announces Annual 2025 Financial And Operating Results
-
Tetragon Financial Group Limited February 2026 Monthly Factsheet
-
Mundys Strengthens Its Strategic Position in Getlink
-
MindMaze Therapeutics and Vibra Healthcare Announce Breakthrough RWE Results in High-Dose, High-Intensity Neurorehabilitation
-
MaaT Pharma Announces 2025 Annual Results and Provides Business Updates
-
Marriott International and Lefay Announce Milestone Deal to Grow Luxury Wellness Offerings Globally
-
Rakuten Mobile Extends Partnership with Netcracker for AI-Enabled Digital BSS to Support its Mobile Network in Japan
-
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
-
ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones

